Reducing the uses of valproate: a controversial decision
Lancet Neurol
.
2024 Feb;23(2):123.
doi: 10.1016/S1474-4422(23)00507-0.
Author
The Lancet Neurology
PMID:
38267170
DOI:
10.1016/S1474-4422(23)00507-0
No abstract available
Publication types
Editorial
MeSH terms
Humans
Valproic Acid* / therapeutic use
Substances
Valproic Acid